Conway Robert E - Insider Stock Trading - OpenInsider

CIK: 1184334 - Address: C/o Alpine Immune Sciences, Inc., 188 East Blaine Street, Suite 200, Seattle, WA 98102

18 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	3	1	8	1	1	-7	-22	-15	1	-7
P	%wins				75	60	25	0	33	67	43

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
9/27/21 07:02	9/23/21	ALPN	Alpine Immune Sciences, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Conway Robert E	WA	D		P.a	151	10.08	0	15	43	50	I
9/23/21 20:31	9/21/21	ALPN	Alpine Immune Sciences, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Conway Robert E	WA	D		P	98	9.80	0	10	40	35	I
5/13/21 17:00	5/12/21	ABIO	Arca Biopharma, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Conway Robert E	CO	DH	Chairman	P	32	3.19	0	10	25	50	D
5/6/21 16:30	5/5/21	ABIO	Arca Biopharma, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Conway Robert E	CO	DH	Chairman	P	32	3.23	0	10	33	40	D
12/21/20 16:15	12/18/20	ABIO	Arca Biopharma, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Conway Robert E	CO	DH	Chairman	P	42	4.16	0	10	50	30	D
11/23/20 17:00	11/19/20	ALPN	Alpine Immune Sciences, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Conway Robert E	WA	D		P	80	8.03	0	10	67	25	I
9/25/20 16:20	9/25/20	ABIO	Arca Biopharma, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Conway Robert E	CO	DH	Chairman	P	21	4.28	0	5	33	20	D
9/24/20 16:20	9/22/20	ABIO	Arca Biopharma, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Conway Robert E	CO	DH	Chairman	P	14	4.66	0	3	26	15	D
9/21/20 17:00	9/21/20	ABIO	Arca Biopharma, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Conway Robert E	CO	DH	Chairman	P	48	4.77	0	10	514	12	D
7/17/17 16:08	7/14/17	ABIO	Arca Biopharma, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Conway Robert E	CO	DH	Chairman	P	25	2.49	0	10	40	35	D
5/11/17 12:17	5/8/17	NVLS	Nivalis Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Conway Robert E	CO	D		P	34	2.28	1	15	33	60	D		-43	-53	0	-17	0	8	5	1
5/10/17 14:00	5/9/17	NVLS	Nivalis Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Conway Robert E	CO	D		P	12	2.34	1	5	13	45	D		-44	-55	1	-18	0	4	2	3
5/9/17 14:01	5/5/17	NVLS	Nivalis Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Conway Robert E	CO	D		P	46	2.30	1	20	100	40	D		-48	-55	-1	-21	-12	5	2	2
5/8/17 14:00	5/4/17	NVLS	Nivalis Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Conway Robert E	CO	D		P	23	2.26	1	10	100	20	D		-48	-59	-6	-19	-17	2	0	1	4
3/27/17 16:06	3/24/17	ABIO	Arca Biopharma, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Conway Robert E	CO	D		P	65	2.59	0	25	New	25	D	-51	-27	-10	2	4	4	6	6	-1	-1	-3
12/11/15 09:01	12/9/15	NVLS	Nivalis Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Conway Robert E	CO	D		P	81	8.10	1	10	New	10	D				-48	-1	-2	-2	-1	0	1	-25	-40	-47	-73
6/17/11 09:51	6/17/11	ARRY	Array Biopharma Inc	DE	Health	Drug	Pharmaceutical Preparations	Conway Robert	CO	DO	CEO	P	54	2.17	1	25	4	656	D	-37	-36	-37	-30	-22	-23	-14	-13	3	6	18	-3	17	56
5/16/11 11:41	5/13/11	ARRY	Array Biopharma Inc	DE	Health	Drug	Pharmaceutical Preparations	Conway Robert	CO	DO	CEO	P	57	2.86	1	20	3	631	D	-6	-21	-13	0	-6	-3	5	1	-1	-7	-17	-23	-15	20

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact